Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter
May 29th, 2019
8.4K views
We describe here methods for sensitive and accurate quantification of the lesions 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo), 1,N6-etheno-2'-deoxyadenosine (1,N6-dAdo) and 1,N2-etheno-2'-deoxyguanosine (1,N2-dGuo) in DNA. The methods were applied to the assessment of the effects of ambient fine particulate matter (PM2.5) in tissues (lung, liver and kidney) of exposed A/J mice.
Overview
This article presents methods for the sensitive and accurate quantification of DNA lesions caused by oxidative stress, specifically 8-oxo-7,8-dihydro-2'-deoxyguanosine and etheno adducts. The techniques were applied to assess the impact of ambient fine particulate matter (PM 2.5) on various tissues in A/J mice.
Key Study Components
Area of Science
- Neuroscience
- Biochemistry
- Toxicology
Background
- Oxidative stress is linked to various pathophysiological processes.
- 8-oxodGuo and etheno adducts are significant DNA lesions.
- HPLC coupled to tandem mass spectrometry is a gold standard for quantification.
- Increased levels of etheno adducts are found in patients with inflammatory diseases.
Purpose of Study
- To quantify DNA lesions induced by oxidative stress.
- To understand the effects of PM 2.5 on DNA integrity.
- To contribute to the prevention and treatment of oxidative stress-related diseases.
Methods Used
- HPLC coupled to tandem mass spectrometry for quantification.
- Analysis of DNA lesions in lung, liver, and kidney tissues.
- Application of methods to biological matrices.
- Assessment of oxidative stress markers in exposed mice.
Main Results
- Demonstrated high selectivity and sensitivity in quantifying DNA lesions.
- Identified significant levels of oxidative DNA damage in tissues.
- Provided insights into the impact of environmental pollutants on DNA integrity.
- Supported the link between oxidative stress and disease mechanisms.
Conclusions
- The methods are effective for studying DNA lesions in complex biological samples.
- Findings highlight the importance of monitoring oxidative stress in health research.
- Further research is needed to explore therapeutic targets for oxidative damage.
Frequently Asked Questions
What are the main DNA lesions discussed in this study?
The study focuses on 8-oxo-7,8-dihydro-2'-deoxyguanosine and etheno adducts.
How does oxidative stress relate to disease?
Oxidative stress is implicated in various inflammatory and degenerative diseases.
What tissues were analyzed in the study?
Lung, liver, and kidney tissues of A/J mice were analyzed.
What is the significance of using HPLC coupled to tandem mass spectrometry?
It provides high selectivity and sensitivity for quantifying DNA lesions.
How can these findings contribute to disease prevention?
Understanding oxidative damage can help identify targets for therapeutic intervention.
What environmental factor was assessed in relation to DNA damage?
Ambient fine particulate matter (PM 2.5) exposure was assessed.
Executive Industry Relevance
Quantification of DNA lesions such as 8-oxo-7,8-dihydro-2'-deoxyguanosine and etheno adducts provides a mechanistic biomarker for oxidative stress and electrophilic damage, supporting target validation in toxicology and disease mechanism research. The HPLC-ESI-MS/MS method enables sensitive, selective detection in complex biological matrices, facilitating preclinical assessment of environmental exposures like ambient PM2.5. This approach aids in de-risking therapeutic hypotheses by linking DNA damage to pathophysiological pathways in inflammation, carcinogenesis, and neurodegenerative disease models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of oxidative stress and lipid peroxidation pathways as mechanistic drivers of DNA damage in disease models.
- Operational Value: Provides quantitative lesion levels per million normal nucleosides, supporting biomarker qualification for target engagement.
- Predictive Value: Supports functional validation of targets involved in DNA repair, oxidative stress response, and electrophile detoxification.
Screening & Assay Development
- Scientific Value: Delivers selective and sensitive quantification of specific DNA lesions, reducing false positives in complex tissue extracts.
- Operational Value: Uses isotopically labeled internal standards to correct for losses during hydrolysis and enrichment, ensuring reproducible measurements across sample batches.
- Assay Readiness: Generates chromatographic peak area ratios that enable comparison across treatment groups and time points in screening campaigns.
Translational & Preclinical Research
- Scientific Value: Measures lesion accumulation in lung, liver, and kidney DNA, offering tissue-specific insight into PM2.5-induced genotoxic stress.
- Translational Continuity: Links environmental exposure to molecular initiating events, supporting extrapolation from animal models to human risk assessment.
- Risk Assessment: Elevated lesion levels correlate with increased cancer risk, informing go/no-go decisions in preclinical safety profiling.
Pipeline & Workflow Integration
The method fits within the discovery continuum from hypothesis testing in early toxicology to mechanistic de-risking in lead optimization, particularly for compounds targeting oxidative stress pathways.
- Discovery Biology: Supports pathway clarification by quantifying DNA lesions as functional readouts of oxidative and electrophilic stress in cellular systems.
- Screening: Enables standardized, reproducible measurement of DNA damage in tissue-derived DNA, facilitating compound effect comparison.
- Analytics: Provides molar fraction outputs (lesions per million normal nucleosides) that allow quantitative comparison across experimental conditions.
- Translational Research: Connects PM2.5 exposure to DNA damage in mammalian tissues, supporting biomarker relevance in preclinical-to-clinical translation.
- Enterprise Reuse: The HPLC-ESI-MS/MS platform can be adapted for other modified nucleosides, creating a reusable capability for genotoxicity assessment across projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing ambiguity in mechanistic links between exposure and DNA damage.
- Operational Value: Ensures standardization and reproducibility through internal normalization and consistent sample preparation.
- Strategic Value: Improves go/no-go decision-making by providing early biomarker evidence of genotoxic risk, reducing late-stage attrition.
- Portfolio Impact: Enables risk-adjusted prioritization of compounds based on DNA lesion profiles in relevant tissue models.
Implementation Considerations
- Requires expertise in DNA isolation, hydrolysis, and HPLC-ESI-MS/MS operation for nucleoside analysis.
- Depends on access to tandem mass spectrometry systems with ESI source and chromatographic switching capabilities.
- Necessitates cross-team standardization of sample handling, internal standard use, and data analysis protocols.
- Must account for tissue-specific DNA yield and lesion stability when adapting to different model systems.
- Practical limitation: Method sensitivity depends on efficient DNA purification and absence of co-eluting interferences in complex matrices.
Biopharma FAQs
Why does quantification of 8-oxo-dGuo matter for target validation?
Quantifying 8-oxo-7,8-dihydro-2'-deoxyguanosine provides a direct measure of oxidative DNA damage, enabling functional validation of targets in oxidative stress response pathways. This supports mechanistic de-risking by linking target modulation to reduced lesion formation in disease-relevant systems.
How does isolation of etheno adducts support discovery pipeline decisions?
Isolating 1,N²-etheno-dGuo and 1,N⁶-etheno-dAdo allows assessment of lipid peroxidation-derived electrophilic damage, helping prioritize compounds that mitigate endogenous genotoxic stress. Quantitative adduct levels inform early screening outcomes by reflecting pathway-specific mechanism engagement.
What enables lesion quantification in tissue DNA samples?
HPLC-ESI-MS/MS with isotopically labeled internal standards enables selective and sensitive quantification of DNA lesions in lung, liver, and kidney DNA. The method corrects for analyte loss and ionization variability, ensuring accurate lesion levels per million normal nucleosides.
Why are replication requirements important for cross-functional collaboration?
Replication ensures consistent lesion quantification across laboratories and sample batches, which is essential for aligning toxicology, pharmacology, and DMPK teams on biomarker reliability. Standardized protocols support data comparability in multi-site preclinical studies.
What statistical analysis is required before implementing lesion quantification?
Implementation requires establishing calibration curves from peak area ratios and calculating molar fractions of lesions to normal nucleosides. Statistical comparison of lesion levels across exposure groups depends on accurate quantification from integrated chromatographic peaks.
